Leukemia

Case Series

Perianal Infections in Patients With Hematologic Malignancy: The Risk of Fournier’s Gangrene Leading to Mortality and Irreversible Organ Damage

09/14/2021

Arife Simsek ;

This article presents a case series of perianal infection progressing to Fournier’s gangrene (FG) in patients with hematologic malignancy to guide physicians.

This article presents a case...

09/14/2021

Wounds

Research in Review

Prior Malignancies Do Not Affect CML Outcomes

11/02/2016

JCP Editors

Patients with chronic myeloid leukemia (CML) and a history of prior malignancies appear to have the same outcomes as patients with no prior malignancies, according to a study published in Cancer. ------ Related...

...

11/02/2016

Journal of Clinical Pathways

Research in Review

Outcomes of Treating ALL With Inotuzumab Ozogamicin

06/14/2016

JCP Editors

A clinical trial assessing the use of inotuzumab ozogamicin in patients with acute lymphoblastic leukemia (ALL) has found that it may be a more effective treatment option than current standard practice. Inotuzumab...

A...

06/14/2016

Journal of Clinical Pathways

Strict Adherence to Ibrutinib Therapy Improves PFS for Chronic Lymphocytic Leukemia

05/05/2016

JCP Editors

Ibrutinib may improve progression-free survival (PFS) for patients with chronic lymphocytic leukemia (CLL) if the full dose is taken on schedule, according to results extracted from clinical trial data and presented...

...

05/05/2016

Journal of Clinical Pathways

Research in Review

High-Dose Treatment for Acute Lymphoblastic Leukemia Safe, Improves Survival

04/29/2016

JCP Editors

Initial results from a clinical trial have shown that high-dose methotrexate may be superior to standard, low-dose regimens without increasing toxicity for children and young adults with high-risk B-acute...

...

04/29/2016

Journal of Clinical Pathways

Research in Review

Imatinib Projected to Be Most Cost-Effective Option for CML

03/14/2016

JCP Editors

According to researchers, imatinib is projected to become the most cost-effective initial treatment strategy for patients with chronic myeloid leukemia in chronic phase (CML-CP) after its patent expires later this...

...

03/14/2016

Journal of Clinical Pathways

Research in Review

Costs for High-Risk Patients With ALL Increasing

02/25/2016

JCP Editors

Costs for high-risk pediatric and adolescent patients with acute lymphoblastic leukemia (ALL) may be higher than standard-risk patients with the disease, according to a recent study. While data regarding health care...

Costs...

02/25/2016

Journal of Clinical Pathways

Research in Review

New Assay More Sensitive for Identifying CML Remission Likely to Relapse

02/10/2016

JCP Editors

A new personalized DNA-based digital polymerase chain reaction (dPCR) assay could help determine which patients with chronic myeloid leukemia (CML) are more likely to relapse while in molecular remission. Advances...

A new...

02/10/2016

Journal of Clinical Pathways

Case Report and Brief Review

Hemicellulose Dressing for Skin Lesions Caused by Herpes Zoster in a Patient With Leukemia—An Alternative Dressing

01/01/2009

Julieta Chacon ;

Lydia Masako Ferreira , MD, PhD;

01/01/2009

Wounds